A carregar...

Afatinib treatment in advanced non-small cell lung cancer

Despite some recent advances in the management of advanced non-small cell lung cancer (NSCLC), prognosis for these patients remains poor. Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have however provided a new therapeutic option in this disease setting an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung Cancer (Auckl)
Main Authors: Hurwitz, Jane L, Scullin, Paula, Campbell, Lynn
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312479/
https://ncbi.nlm.nih.gov/pubmed/28210118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S16310
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!